Checkmate Pharmaceuticals Inc
NASDAQ:CMPI
Income Statement
Earnings Waterfall
Checkmate Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-63.2m
USD
|
Operating Income
|
-63.2m
USD
|
Other Expenses
|
20k
USD
|
Net Income
|
-63.2m
USD
|
Income Statement
Checkmate Pharmaceuticals Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||
Operating Expenses |
(29)
|
(30)
|
(31)
|
(34)
|
(37)
|
(43)
|
(54)
|
(59)
|
(61)
|
(63)
|
|
Selling, General & Administrative |
(5)
|
(5)
|
(6)
|
(8)
|
(10)
|
(12)
|
(15)
|
(15)
|
(16)
|
(16)
|
|
Research & Development |
(24)
|
(24)
|
(25)
|
(27)
|
(27)
|
(31)
|
(39)
|
(44)
|
(46)
|
(47)
|
|
Operating Income |
(29)
N/A
|
(30)
-2%
|
(31)
-4%
|
(34)
-12%
|
(37)
-8%
|
(43)
-17%
|
(54)
-25%
|
(59)
-10%
|
(61)
-4%
|
(63)
-3%
|
|
Pre-Tax Income | |||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(28)
N/A
|
(29)
-2%
|
(30)
-5%
|
(34)
-12%
|
(37)
-9%
|
(43)
-17%
|
(54)
-25%
|
(59)
-10%
|
(61)
-4%
|
(63)
-3%
|
|
Net Income | |||||||||||
Income from Continuing Operations |
(28)
|
(29)
|
(30)
|
(34)
|
(37)
|
(43)
|
(54)
|
(59)
|
(61)
|
(63)
|
|
Net Income (Common) |
(28)
N/A
|
(29)
-2%
|
(30)
-5%
|
(34)
-12%
|
(37)
-9%
|
(43)
-17%
|
(54)
-25%
|
(59)
-10%
|
(61)
-4%
|
(63)
-3%
|
|
EPS (Diluted) |
-1.32
N/A
|
-1.35
-2%
|
-1.41
-4%
|
-1.57
-11%
|
-1.71
-9%
|
-2
-17%
|
-2.49
-25%
|
-2.73
-10%
|
-2.84
-4%
|
-2.92
-3%
|